Trauma News and Research

RSS

Solgar voluntarily recalls ABC Dophilus Powder

Solgar, Inc., of Leonia, NJ, is voluntarily recalling ABC Dophilus Powder. The recall was initiated, out of an abundance of caution, because the product was found to contain Rhizopus oryzae, which may cause Mucormycosis.

16 Nov 2014

University at Buffalo researchers receive $500,000 grant to study IED-induced vision loss

It's well known that battlefield explosions can cause hearing loss, but veterans may be surprised to learn that their vision may also suffer — sometimes weeks or months after combat exposure.

14 Nov 2014

Researchers identify molecular switch that controls inflammatory processes in aging-related disorders

A study led by Massachusetts General Hospital (MGH) investigators has identified what appears to be a molecular switch controlling inflammatory processes involved in conditions ranging from muscle atrophy to Alzheimer's disease.

14 Nov 2014

New findings may help develo injury-prevention measures

This week's issue of the New England Journal of Medicine features an article that highlights an unprecedented analysis of the nation's childhood head injuries. The study, authored by

14 Nov 2014

Load bearing, biodegradable implants can reduce the number of second surgeries

No other joint in the human body is as highly mobile as is the shoulder. However, it is also very sensitive and prone to injury, with athletes being particularly affected.

14 Nov 2014

Study offers unprecedented picture of how children frequently suffer head injuries

A study in which more than 43,000 children were evaluated for head trauma offers an unprecedented picture of how children most frequently suffer head injuries, report physicians at Washington University School of Medicine in St. Louis and the University of California, Davis, School of Medicine.

13 Nov 2014

Scientists receive NARSAD Distinguished Investigator Grants for mental health research

The Brain & Behavior Research Foundation today announced the award of NARSAD Distinguished Investigator Grants valued at $1.5 million to 15 scientists, who are full professors or the equivalent, conducting innovative projects in diverse areas of neurobiological and behavioral research.

13 Nov 2014

K2M receives FDA clearance to market CAPRI Corpectomy Cage System

K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market the CAPRI Corpectomy Cage System, an expandable vertebral body replacement device that provides structural stability following a corpectomy or vertebrectomy.

13 Nov 2014

New study reveals promising path for rehabilitation of mild traumatic brain injury patients

As football players are learning, a violent blow to the head has the potential to cause mild to severe traumatic brain injury -- physical damage to the brain that can be debilitating, even fatal. The long-term effects run the gamut of human functioning, from trouble communicating to extensive cognitive and behavioral deterioration. To date, there is no effective medical or cognitive treatment for patients with traumatic brain injuries.

12 Nov 2014

Prescription opioids involved in 67.8% of nationwide ED visits in 2010, find researchers

Researchers from Rhode Island and The Miriam hospitals and the Stanford University School of Medicine have found that prescription opioids, including methadone, were involved in 67.8 percent of (or over 135,971 visits to) nationwide emergency department (ED) visits in 2010, with the highest proportion of opioid overdoses occurring in the South.

12 Nov 2014

Actamax reports positive results from first clinical study of novel sprayable adhesion barrier device

Actamax Surgical Materials LLC, a DSM-DuPont Joint Venture focusing on the development and commercialization of resorbable, biocompatible surgical medical devices, today announced positive safety and efficacy results from the first clinical evaluation of its novel adhesion barrier device.

11 Nov 2014

Peter Munk Cardiac Centre surgeons successfully implant novel heart device

A surgical team at the Peter Munk Cardiac Centre led by internationally-acclaimed cardiovascular surgeon, Dr. Vivek Rao, has successfully implanted a novel mechanical device, the HeartMate IIITM, into a patient with advanced heart failure.

11 Nov 2014

JPRAS Open: New open access journal from Elsevier

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of a new, online-only open access journal, JPRAS Open .

10 Nov 2014

Worst effects of reperfusion injury after heart attack may be prevented with iodide

Blocked arteries are typically the trigger, stopping the flow of blood and starving the heart muscle of oxygen. But when the blockage is removed and the blood comes rushing back, it wreaks havoc of its own. The result is called reperfusion injury, a life-threatening flood of inflammation and cellular destruction that has stumped scientists for 40 years.

9 Nov 2014

BioElectronics to present innovative chronic pain therapy at OTC Pharma Asia Conference

BioElectronics Corporation, the maker of advanced consumer and healthcare medical devices announced today that its Executive Vice President, Dr. Deepak Kotak has been invited to present BioElectronics' innovative chronic pain therapy at the OTC Pharma Asia Conference, on Tuesday, March 3, 2015 in Singapore.

5 Nov 2014

Hemp Health launches CBD wellness supplements

Hemp Health Inc., a pioneer in hemp cannabidiol (CBD) products, today launched their line of CBD wellness supplements. Available in oil, spray and capsule form, Hemp Health's products offer a compelling alternative to medical marijuana. The CBD supplements provide consumers with the therapeutic ingredient in hemp while allowing them to avoid the negative mental and physical effects of marijuana.

4 Nov 2014

Ruthigen enrolls first patient in Phase 1/2 clinical trial of RUT58-60

Ruthigen, Inc., announced today enrollment of the first patient in a Randomized, Double-Blind Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.

4 Nov 2014

New therapy appears to help tinnitus patients cope better with phantom noise

Patients with tinnitus hear phantom noise and are sometimes so bothered by the perceived ringing in their ears, they have difficulty concentrating. A new therapy does not lessen perception of the noise but appears to help patients cope better with it in their daily lives, according to new research.

31 Oct 2014

New Ethicon stapling solution provides least tissue slippage during firing

Ethicon announced today the launch of the ECHELON FLEX GST SYSTEM, a new powered stapler and reload system uniquely designed to provide a better grip on tissue for the least tissue slippage during firing. The device will be featured at The American College of Surgeons Clinical Conference in San Francisco this week.

29 Oct 2014

Clementia initiates Phase 2 extension study of palovarotene in FOP patients

Clementia Pharmaceuticals, Inc. announced today the initiation of a Phase 2 extension study of palovarotene in patients with fibrodysplasia ossificans progressiva (FOP), a rare, severely disabling genetic disease characterized by painful, recurrent episodes of soft tissue swelling (flare-ups) and new abnormal bone formation.

27 Oct 2014

Trauma News and Research

Solgar voluntarily recalls ABC Dophilus Powder

University at Buffalo researchers receive $500,000 grant to study IED-induced vision loss

Researchers identify molecular switch that controls inflammatory processes in aging-related disorders

New findings may help develo injury-prevention measures

Load bearing, biodegradable implants can reduce the number of second surgeries

Study offers unprecedented picture of how children frequently suffer head injuries

Scientists receive NARSAD Distinguished Investigator Grants for mental health research

K2M receives FDA clearance to market CAPRI Corpectomy Cage System

New study reveals promising path for rehabilitation of mild traumatic brain injury patients

Prescription opioids involved in 67.8% of nationwide ED visits in 2010, find researchers

Actamax reports positive results from first clinical study of novel sprayable adhesion barrier device

Peter Munk Cardiac Centre surgeons successfully implant novel heart device

JPRAS Open: New open access journal from Elsevier

Worst effects of reperfusion injury after heart attack may be prevented with iodide

BioElectronics to present innovative chronic pain therapy at OTC Pharma Asia Conference

Hemp Health launches CBD wellness supplements

Ruthigen enrolls first patient in Phase 1/2 clinical trial of RUT58-60

New therapy appears to help tinnitus patients cope better with phantom noise

New Ethicon stapling solution provides least tissue slippage during firing

Clementia initiates Phase 2 extension study of palovarotene in FOP patients

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News